ES488120A1 - Procedimiento para la preparacion de corticoide-17-alcohil- carbonatos - Google Patents

Procedimiento para la preparacion de corticoide-17-alcohil- carbonatos

Info

Publication number
ES488120A1
ES488120A1 ES488120A ES488120A ES488120A1 ES 488120 A1 ES488120 A1 ES 488120A1 ES 488120 A ES488120 A ES 488120A ES 488120 A ES488120 A ES 488120A ES 488120 A1 ES488120 A1 ES 488120A1
Authority
ES
Spain
Prior art keywords
alkylcarbonates
corticoids
preparation
medicines against
dermatoses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES488120A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES488120A1 publication Critical patent/ES488120A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0042—Nitrogen only
    • C07J71/0047—Nitrogen only at position 2(3)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Procedimiento que consiste en que se transforman en complejos los cationes de los halogenuros metálicos mencionados anteriormente con compuestos adecuados para la formación de complejos, preferentemente con "eteres corona" (formación de criptatos), con lo cual, debido al aumento del grado de nucleofilia de los correspondientes iones de halogenuros, producido con ello, se efectúa correspondiente intercambio de radical sulfonato por halogeno ya a una temperatura de 0º hasta 30ºC de manera practicable y suficiente.
ES488120A 1978-04-25 1980-01-31 Procedimiento para la preparacion de corticoide-17-alcohil- carbonatos Expired ES488120A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782817988 DE2817988A1 (de) 1978-04-25 1978-04-25 Corticoid 17-alkylcarbonate und verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
ES488120A1 true ES488120A1 (es) 1980-09-16

Family

ID=6037909

Family Applications (2)

Application Number Title Priority Date Filing Date
ES479709A Expired ES479709A1 (es) 1978-04-25 1979-04-19 Procedimiento para la preparacion de corticoide-17-alcohil- carbonatos.
ES488120A Expired ES488120A1 (es) 1978-04-25 1980-01-31 Procedimiento para la preparacion de corticoide-17-alcohil- carbonatos

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES479709A Expired ES479709A1 (es) 1978-04-25 1979-04-19 Procedimiento para la preparacion de corticoide-17-alcohil- carbonatos.

Country Status (19)

Country Link
US (1) US4377575A (es)
EP (1) EP0004975B1 (es)
JP (1) JPS54144357A (es)
AR (1) AR226157A1 (es)
AT (1) AT372094B (es)
AU (1) AU529172B2 (es)
CA (1) CA1130276A (es)
DE (2) DE2817988A1 (es)
DK (1) DK157880C (es)
ES (2) ES479709A1 (es)
FI (1) FI791307A7 (es)
GR (1) GR72886B (es)
HU (1) HU180788B (es)
IE (1) IE48328B1 (es)
IL (1) IL57114A (es)
NO (1) NO791365L (es)
NZ (1) NZ190256A (es)
PT (1) PT69544A (es)
ZA (1) ZA791941B (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996335A (en) * 1980-07-10 1991-02-26 Nicholas S. Bodor Soft steroids having anti-inflammatory activity
SE449106B (sv) * 1980-07-10 1987-04-06 Otsuka Pharma Co Ltd Steroid med anti-inflammatorisk verkan samt komposition innehallande denna
JPS5835199A (ja) * 1981-08-26 1983-03-01 Mitsubishi Chem Ind Ltd モノヨ−ドステロイドおよびその製造法
JPS58103400A (ja) * 1981-12-11 1983-06-20 Ota Seiyaku Kk ６α−メチルプレドニゾロン誘導体
AU558725B2 (en) * 1983-09-07 1987-02-05 Mitsubishi Kasei Corporation Corticoid derivatives
JPS6056997A (ja) * 1983-09-07 1985-04-02 Mitsubishi Chem Ind Ltd 新規な６−酸素化コルチコイド／７α−カ−ボネ−ト誘導体およびその製法
DE4025342A1 (de) * 1990-08-10 1992-02-13 Hoechst Ag In 17-stellung substituierte corticoid-17-alkylcarbonate, verfahren zu deren herstellung und diese enthaltende arzneimittel
DE4328819A1 (de) * 1993-08-27 1995-03-02 Hoechst Ag Corticosteroid-17-alkylcarbonat-21/0/-Carbonsäure- und Kohlensäureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE4333920A1 (de) 1993-10-05 1995-04-13 Hoechst Ag Corticoid-17,21-dicarbonsäureester sowie Corticosteroid-17-carbonsäureester-21-kohlensäureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE4433374A1 (de) * 1994-09-20 1996-03-21 Hoechst Ag 17-Desoxi-corticosteroid-21-/O/-Carbonsäure- ester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
EP2067784A3 (en) * 2000-08-05 2012-08-22 Glaxo Group Limited 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivatives as anti-inflammatory agents
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6777399B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6787532B2 (en) * 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6858593B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6750210B2 (en) * 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6777400B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
UA77656C2 (en) * 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
WO2002088167A1 (en) * 2001-04-30 2002-11-07 Glaxo Group Limited Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US7208485B2 (en) * 2003-01-13 2007-04-24 Chemagis Ltd. Crystalline forms of halobetasol propionate
US20040138192A1 (en) * 2003-01-13 2004-07-15 Chemagis Ltd. Crystalline forms of halobetasol propionate
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
EP2207788A1 (en) * 2007-10-04 2010-07-21 AstraZeneca AB Steroidal [3, 2-c]pyrazole compounds, with glucocorticoid activity
CA2707618A1 (en) * 2007-12-20 2009-07-02 Astrazeneca Ab Steroid derivatives acting as glucocorticosteroid receptor agonists
UY32521A (es) * 2009-04-03 2010-10-29 Astrazeneca Ab Combinación para emplear en el tratamiento de enfermedades respiratorias
UY32523A (es) * 2009-04-03 2010-10-29 Astrazeneca Ab Compuestos que tienen actividad agonista del receptor de glucocorticosteroides
UY32520A (es) * 2009-04-03 2010-10-29 Astrazeneca Ab Compuestos que tienen actividad agonista del receptor de glucocorticoesteroides
UY32525A (es) * 2009-04-03 2010-10-29 Astrazeneca Ab Compuestos que tienen actividad agonista del receptor de glucocorticosteroides

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1668451U (de) 1953-09-22 1953-12-10 Heinrich Loos Naehmaschinen-antrieb.
GB885092A (en) 1958-05-15 1961-12-20 Upjohn Co Improvements in or relating to steroids and the manufacture thereof
GB1253831A (en) * 1968-01-19 1971-11-17 Glaxo Lab Ltd 9alpha,21-DIHALOPREGNANE COMPOUNDS
GB1281689A (en) * 1968-10-14 1972-07-12 Glaxo Lab Ltd Steroid 21-phosphates
US3558675A (en) * 1969-06-30 1971-01-26 Merck & Co Inc Steroid carbonates and process
GB1440063A (en) * 1972-08-11 1976-06-23 Glaxo Lab Ltd 17alpha-esters of 17alpha,21-dihydroxy-20-oxo-steroids
JPS5032163A (es) 1973-07-05 1975-03-28
US3832366A (en) 1973-07-30 1974-08-27 Squibb & Sons Inc Process for preparing 21-chloro-17-acyloxy-20-ketosteroids
YU54476A (en) 1975-03-31 1982-05-31 Taisho Pharmaceutical Co Ltd Process for obtaining 17-ester 21-halo-pregnane
US4021459A (en) * 1975-08-14 1977-05-03 Schering Corporation Process for the preparation of 21-halogeno-21-desoxy-17α-acyloxy 20-keto-pregnenes
DE2735110A1 (de) * 1977-08-04 1979-02-15 Hoechst Ag Corticoid-17-alkylcarbonate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
PT69544A (de) 1979-05-01
JPS6252759B2 (es) 1987-11-06
AU529172B2 (en) 1983-05-26
IL57114A0 (en) 1979-07-25
DE2962122D1 (en) 1982-03-25
GR72886B (es) 1984-01-02
DK157880C (da) 1990-07-30
DK157880B (da) 1990-02-26
ATA307479A (de) 1983-01-15
EP0004975A3 (en) 1979-11-14
EP0004975A2 (de) 1979-10-31
US4377575A (en) 1983-03-22
IE48328B1 (en) 1984-12-12
ZA791941B (en) 1980-04-30
NZ190256A (en) 1981-03-16
EP0004975B1 (de) 1982-02-17
JPS54144357A (en) 1979-11-10
AR226157A1 (es) 1982-06-15
IE790831L (en) 1979-10-25
CA1130276A (en) 1982-08-24
HU180788B (en) 1983-04-29
ES479709A1 (es) 1980-08-16
DE2817988A1 (de) 1979-11-08
NO791365L (no) 1979-10-26
IL57114A (en) 1983-11-30
DK168579A (da) 1979-10-26
FI791307A7 (fi) 1981-01-01
AT372094B (de) 1983-08-25

Similar Documents

Publication Publication Date Title
ES479709A1 (es) Procedimiento para la preparacion de corticoide-17-alcohil- carbonatos.
ES472147A1 (es) Procedimiento para la preparacion de nuevos esteroido-17- alcohilcarbonatos.
CS410191A3 (en) Benzimidazoles, process of their preparation and medicaments comprising said compounds
DE2960222D1 (en) Phenoxyalkylcarboxylic-acid derivatives, process for their preparation and medicaments containing them
AU511754B2 (en) Continuous method for production of ethanol
DE2961983D1 (en) Pyrrolidine-2-methanol derivatives, process for their preparation and medicaments containing them
KE3215D (en) Method of treating protozoal diseases
JO992B1 (en) A new class of N-phenyl derivatives 1-3-oxazolidine 2-4- debt has a fungicide effect and a way to prepare these compounds
DE2963947D1 (en) Process for the manufacture of sodium amoxicillin preparations
DE2964198D1 (en) Indanamine derivatives, process for their preparation and medicaments containing them
AU5331979A (en) Termentation process for production of xanthan
EP0004624A3 (en) Chromanon derivatives, process for their preparation, and their use as medicines and growth-promoting agents
DE2962886D1 (en) Derivatives of l-cysteine, their use as medicaments and process for their preparation
IL59768A0 (en) New prostaglandin derivatives in the 6-keto-pge series
DE2961524D1 (en) Glycofuranosyl-nitrosourea derivatives, process for their manufacture and their pharmaceutical preparations
HK58085A (en) Novel azathianaphthalene derivatives,process for their manufacture,pharmaceutical preparations containing them and their use
ZA795565B (en) New benzimidazolylcarbamic acid esters their production, and their medicinal use
DE2961424D1 (en) Process for the production of 2-substituted 1-alkyl-nitroimidazoles
DE2960069D1 (en) Process for the manufacture of n,n-dimethylaminoacetonitrile
AU513409B2 (en) Preparations of 3-N-pyrrolidino-4-phenoxy-5 sulfamylbenzoic acid and process for their manufacture
SU583185A1 (ru) Способ термической обработки деталей
ZA793991B (en) Novel prostaglandin derivatives of the delta 2-11-desoxy-pgf2 or pge2 series,process for their manufacture and their use as medicaments
JPS5246254A (en) Joint manufacturing process
DE2965198D1 (en) Steroid intermediate, method for production thereof and method of producing another steroid intermediate therefrom
GB2036736B (en) Process for the production of 2-alkoxy-4,6-dichloros-triazines

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519